Your browser doesn't support javascript.
loading
Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
Miyazawa, Motoki; Katsuda, Masahiro; Maguchi, Hiroyuki; Katanuma, Akio; Ishii, Hiroshi; Ozaka, Masato; Yamao, Kenji; Imaoka, Hiroshi; Kawai, Manabu; Hirono, Seiko; Okada, Ken-Ichi; Yamaue, Hiroki.
Affiliation
  • Miyazawa M; Second Department of Surgery, Wakayama Medical University School of Medicine, Japan.
  • Katsuda M; Second Department of Surgery, Wakayama Medical University School of Medicine, Japan.
  • Maguchi H; Center for Gastroenterology, Teine-Keijinkai Hospital, Japan.
  • Katanuma A; Center for Gastroenterology, Teine-Keijinkai Hospital, Japan.
  • Ishii H; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan.
  • Ozaka M; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Japan.
  • Yamao K; Department of Gastroenterology, Aichi Cancer Center Hospital, Japan.
  • Imaoka H; Department of Gastroenterology, Aichi Cancer Center Hospital, Japan.
  • Kawai M; Second Department of Surgery, Wakayama Medical University School of Medicine, Japan.
  • Hirono S; Second Department of Surgery, Wakayama Medical University School of Medicine, Japan.
  • Okada KI; Second Department of Surgery, Wakayama Medical University School of Medicine, Japan.
  • Yamaue H; Second Department of Surgery, Wakayama Medical University School of Medicine, Japan.
Int J Cancer ; 140(4): 973-982, 2017 02 15.
Article in En | MEDLINE | ID: mdl-27861852
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Immunotherapy, Active / Kinesins / Cancer Vaccines / Carcinoma, Pancreatic Ductal / Vaccines, Subunit / Vascular Endothelial Growth Factor Receptor-1 / Vascular Endothelial Growth Factor Receptor-2 / HLA-A24 Antigen / Neoplasm Proteins Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Immunotherapy, Active / Kinesins / Cancer Vaccines / Carcinoma, Pancreatic Ductal / Vaccines, Subunit / Vascular Endothelial Growth Factor Receptor-1 / Vascular Endothelial Growth Factor Receptor-2 / HLA-A24 Antigen / Neoplasm Proteins Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2017 Document type: Article Affiliation country: Country of publication: